Stocks and Investing Stocks and Investing
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019

Charles Duncan Maintained (AXSM) at Buy with Increased Target to $25 on, Mar 21st, 2019


Published on 2024-10-26 12:43:06 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $16 to $25 on, Mar 21st, 2019.

Charles, nor any peers, have made any analyst calls on AXSM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources